Ras oncogenes: split personalities

Cited by (1,000)

Items 301–400 of 1,000

1. Assessment of K‐ras mutation
   Yixing Jiang, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Hua Cheng, Jaffer A. Ajani · 2009 · Cancer
2. Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
   Tobias J. Grob, Uwe Heilenkötter, Stefan Geist, Peter Paluchowski, Christian Wilke, Fritz Jaenicke, Alexander Quaas, Waldemar Wilczak, Matthias Choschzick, Guido Sauter et al. · 2012 · Breast Cancer Research and Treatment
3. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection
   Keith Meyer, Young-Chan Kwon, Shuanghu Liu, Curt H. Hagedorn, Ratna B. Ray, Ranjit Ray · 2015 · Scientific Reports
4. Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells
   Meng‐Tzu Weng, Jih‐Hsiang Lee, Shu‐Chen Wei, Qiuning Li, Sina Shahamatdar, Dennis J. Hsu, Aaron J. Schetter, Stephen Swatkoski, Poonam Mannan, Susan H. Garfield et al. · 2012 · Proceedings of the National Academy of Sciences
5. c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway
   Jens Rauch, Kim Moran‐Jones, Valerie S. Albrecht, Thomas Schwarzl, Keith David Hunter, Olivier Gires, Walter Kölch · 2011 · Cancer Research
6. Molecular Characteristics of Clostridium perfringens TpeL Toxin and Consequences of Mono-O-GlcNAcylation of Ras in Living Cells
   Gregor Guttenberg, Sven Hornei, Thomas Jank, Carsten Schwan, Wei Lü, Oliver Einsle, Panagiotis Papatheodorou, Klaus Aktories · 2012 · Journal of Biological Chemistry
7. Identification of a Small GTPase Inhibitor Using a High-Throughput Flow Cytometry Bead-Based Multiplex Assay
   Zurab Surviladze, Anna Waller, Yang Wu, Elsa Romero, Bruce S. Edwards, Angela Wandinger‐Ness, Larry A. Sklar · 2009 · SLAS DISCOVERY
8. Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines
   Vartanian, Steffan, Bentley, Carolyn, Brauer, Matthew J., Li, Li, Shirasawa, Senji, Sasazuki, Takehiko, Kim, Jung-Sik, Haverty, Pete, Stawiski, Eric, Modrusan, Zora et al. · 2013 · Journal of Biological Chemistry
9. Extracellular vesicles from apoptotic BMSCs ameliorate osteoporosis via transporting regenerative signals
   Maojiao Li, Qi Tang, Chengcheng Liao, Zhuo Wang, Siyuan Zhang, Qingqing Liang, Cheng Liang, Xiaodong Liu, Jingyi Zhang, Weidong Tian et al. · 2024 · Theranostics
10. Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies
    Semir Vranić, Zoran Gatalica, Zhaoyi Wang · 2011 · Oncology Letters
11. Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins
    Yuanhao Wang, Dong Ji, Chaoyu Lei, Yingfei Chen, Yuran Qiu, Xinyi Li, Mingyu Li, Duan Ni, Jun Pu, Jian Zhang et al. · 2021 · Computational and Structural Biotechnology Journal
12. Segregation of Negatively Charged Phospholipids by the Polycationic and Farnesylated Membrane Anchor of Kras
    Lorant Janosi, Alemayehu Abebe Gorfe · 2010 · Biophysical Journal
13. DAB2IP in cancer
    Liang Liu, Cong Xu, Jer‐Tsong Hsieh, Jianping Gong, Daxing Xie · 2015 · Oncotarget
14. Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling
    Andreas N. WICKI, Mario Mandalà, Daniela Massi, Daniela Taverna, Huifang Tang, Brian A. Hemmings, Gongda Xue · 2016 · Physiological Reviews
15. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis
    Galit Lazer, Yulia Idelchuk, Vered Schapira, Eli Pikarsky, Shulamit Katzav · 2009 · The Journal of Pathology
16. Rational Design of Small Molecule Inhibitors Targeting the Ras GEF, SOS1
    Chris R. Evelyn, Xin Duan, Jacek Biesiada, William L. Seibel, Jarek Meller, Yi Zheng · 2014 · Chemistry & Biology
17. Emerging biological functions of the vaccinia-related kinase (VRK) family.
    Elke P.F. Klerkx, Pedro A. Lazo, Peter Askjaer · 2009 · PubMed
18. RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage
    Zubaidah M. Ramdzan, Charles Vadnais, Ranjana Pal, Guillaume Vandal, Chantal Cadieux, Lam Leduy, Sayeh Davoudi, Laura Hulea, Lu Yao, Anthony Nicholas Karnezis et al. · 2014 · PLoS Biology
19. Interfering with RAS–effector protein interactions prevent RAS-dependent tumour initiation and causes stop–start control of cancer growth
    Tomoyuki U Tanaka, Terence Howard Rabbitts · 2010 · Oncogene
20. H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice
    Taeko Ichise, Nobuaki Yoshida, Hirotake Ichise · 2010 · Development
21. Dynamics of Membrane-Bound G12V-KRAS from Simulations and Single-Molecule FRET in Native Nanodiscs
    Priyanka Prakash, Douglas B. Litwin, Liang Hong, Suparna Sarkar‐Banerjee, Drew M. Dolino, Yong Zhou, John F. Hancock, Vasanthi Jayaraman, Alemayehu Abebe Gorfe · 2018 · Biophysical Journal
22. K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function
    Shufen Cao, Stacey Chung, SoonJeung Kim, Zhenlu Li, Danny Manor, Matthias Buck · 2019 · Journal of Biological Chemistry
23. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells
    Sen, Madhobi, Wang, Xin, Hamdan, Feda H., Rapp, Jacobe, Eggert, Jessica, Kosinsky, Robyn Laura, Wegwitz, Florian, Kutschat, Ana Patricia, Younesi, Fereshteh S., Gaedcke, Jochen et al. · 2019 · Clinical Epigenetics
24. Overcoming Resistance to Drugs Targeting KRAS Mutation
    Jiao, Delong, Yang, Shengyu · 2020 · The Innovation
25. Formation and Domain Partitioning of H-ras Peptide Nanoclusters: Effects of Peptide Concentration and Lipid Composition
    Zhenlong Li, Lorant Janosi, Alemayehu Abebe Gorfe · 2012 · Journal of the American Chemical Society
26. The Ras–Membrane Interface: Isoform-Specific Differences in the Catalytic Domain
    Jillian A. Parker, Carla Mattos · 2015 · Molecular Cancer Research
27. One-way membrane trafficking of SOS in receptor-triggered Ras activation
    Sune M. Christensen, Hsiung‐Lin Tu, Jesse E. Jun, Steven A. Alvarez, Meredith Gahn Triplet, Jeffrey S. Iwig, Kamlesh Kumar Yadav, Dafna Bar‐Sagi, Jeroen P. Roose, Jay T. Groves · 2016 · Nature Structural & Molecular Biology
28. Structure of two G-quadruplexes in equilibrium in the KRAS promoter
    Julien Marquevielle, Coralie Robert, Olivier Lagrabette, Mona Wahid, Anne Bourdoncle, Luigi Emilio Xodo, Jean‐Louis Mergny, Gilmar F. J. Salgado · 2020 · Nucleic Acids Research
29. Ras and Raf pathways in epidermis development and carcinogenesis
    F Kern, Théodora Niault, Manuela Baccarini · 2010 · British Journal of Cancer
30. The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis
    Barbara Mátyási, Zsolt Farkas, László Kopper, Anna Réka Sebestyén, Mathieu Boissan, Anil Mehta, Krisztina Takács‐Vellai · 2020 · Pathology & Oncology Research
31. The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulatesKRASexpression in pancreatic ductal adenocarcinoma cells
    Suravi Pramanik, Yingling Chen, Heyu Song, Irine Khutsishvili, Luis A. Marky, Sutapa Ray, Amarnath Natarajan, Pankaj K. Singh, Kishor K. Bhakat · 2022 · Nucleic Acids Research
32. Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy
    Sara Alves, Lisandra Castro, Maria Sofia Fernandes, Rita Francisco, P.J.T.D. Castro, Muriel Priault, Susana Rodrigues Chaves, Mary Pat Moyer, Carla Oliveíra, Raquel Seruca et al. · 2015 · Oncotarget
33. RasGRP3 limits Toll-like receptor-triggered inflammatory response in macrophages by activating Rap1 small GTPase
    Songqing Tang, Taoyong Chen, Yu Zhou, Xuhui Zhu, Mingjin Yang, Bin Xie, Nan Li, Xuetao Cao, Jianli Wang · 2014 · Nature Communications
34. Transmembrane signaling in Saccharomyces cerevisiae as a model for signaling in metazoans: State of the art after 25years
    David Engelberg, Riki Perlman, Alexander Levitzki · 2014 · Cellular Signalling
35. Functional Redundancy of Sos1 and Sos2 for Lymphopoiesis and Organismal Homeostasis and Survival
    Fernando C. Baltanás, Martín Pérez‐Andrés, Alicia Ginel-Picardo, David Díaz, David Jimeno, Pilar Liceras-Boillos, Robert L. Kortum, Lawrence E. Samelson, Alberto Órfão, Eugenio Santos · 2013 · Molecular and Cellular Biology
36. Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands
    Xi V. Liu, Samantha S.W. Ho, James J. Tan, Neha Kamran, Stephan Gasser · 2012 · The Journal of Immunology
37. Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice
    Maria E. Balasis, Kara D. Forinash, Y. Ann Chen, William J. Fulp, Domenico Coppola, Andrew D. Hamilton, Jin Quan Cheng, Saı̈d M. Sebti · 2011 · Clinical Cancer Research
38. Arteriovenous Malformations and Other Vascular Malformation Syndromes
    Kevin J. Whitehead, Matthew C. P. Smith, D. Y. Li · 2012 · Cold Spring Harbor Perspectives in Medicine
39. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas
    Serrano, César, Romagosa, Cleofé, Hernández‐Losa, Javier, Simonetti, Sara, Valverde, Claudia, Moliné, Teresa, Somoza, Rosa, Pérez, Manuel, Vélez, Roberto, Vergés, Ramona et al. · 2016 · Cancer
40. Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy
    Yunli Huang, Yongqi Zhen, Yanmei Chen, Shaoguang Sui, Lan Zhang · 2023 · Biochemical Pharmacology
41. The role of the small GTP ase Rab31 in cancer
    Christelle En Lin Chua, Bor Luen Tang · 2014 · Journal of Cellular and Molecular Medicine
42. Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer
    Alfonso Sánchez‐Muñoz, Elena Gallego, Vanessa de Luque, Luis Gustavo Perez‐Rivas, Luís Vicioso, Nuria Ribelles, José Lozano, Emilio Alba · 2010 · BMC Cancer
43. The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis
    Giulia Cazzanelli, Flávia Dayana Silva Pereira, Sara Alves, Rita Francisco, Luı́sa Azevedo, Patrícia Dias Carvalho, Ana F. Almeida, Manuela Côrte‐Real, María José Oliveira, Cândida Lucas et al. · 2018 · Cells
44. Chronicles of the GTPase switch
    Jacqueline Cherfils, Mahel Zeghouf · 2011 · Nature Chemical Biology
45. Endometrial Carcinoma: Specific Targeted Pathways
    Núria Eritja, Andrée Yeramian, Bo‐Juen Chen, David Llobet‐Navàs, Eugenia Ortega, Eva Colás, Miguel Abal, Xavier Dolcet, Jaume Reventós, Xavier Matías‐Guiu · 2016 · Advances in experimental medicine and biology
46. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway
    Juwon Jang, Min‐Kyu Kim, Suk‐Chul Bae · 2018 · Small GTPases
47. Synthetic Lethal Therapy for KRAS Mutant Non-small-cell Lung Carcinoma with Nanoparticle-mediated CDK4 siRNA Delivery
    Chengqiong Mao, Menghua Xiong, Yang Liu, Song Shen, Xiao‐Jiao Du, Xianzhu Yang, Shuang Dou, Peizhuo Zhang, Jun Wang · 2014 · Molecular Therapy
48. A novel role of farnesylation in targeting a mitotic checkpoint protein, human Spindly, to kinetochores
    Devinderjit Kaur Moudgil, Nathan P. Westcott, Jakub K. Famulski, Kinjal Patel, Dawn Macdonald, Howard C. Hang, Gordon K. T. Chan · 2015 · The Journal of Cell Biology
49. Selective requirement for Mediator MED23 in Ras-active lung cancer
    Yang Xu, Meng Liang Zhao, Min Hao Xia, Yuting Liu, Jun Yan, Hongbin Ji, Gang Wang · 2012 · Proceedings of the National Academy of Sciences
50. The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
    Michael Grusch, Michaela Petz, Thomas Metzner, Deniz Gülfem Öztürk, Doris Schneller, Wolfgang Mikulits · 2010 · Current Cancer Drug Targets
51. Dock GEFs and their therapeutic potential: Neuroprotection and axon regeneration
    Namekata, Kazuhiko, Kimura, Atsuko, Kawamura, Kazuto, Harada, Chikako, Harada, Takayuki · 2014 · Progress in Retinal and Eye Research
52. The Plasma Membrane as a Competitive Inhibitor and Positive Allosteric Modulator of KRas4B Signaling
    Neale, Chris, García, Angel E. · 2020 · Biophysical Journal
53. KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways
    Koushik Mondal, Mahesh Kumar Posa, Revathi Panduranga Shenoy, Susanta Roychoudhury · 2024 · Cells
54. Improving the Limit of Detection for Sanger Sequencing: A Comparison of Methodologies for KRAS Variant Detection
    Colin J. Davidson, Emily Zeringer, Kristen J. Champion, Marie‐Pierre L. Gauthier, Fawn Wang, Jerry Boonyaratanakornkit, Julie R. Jones, Edgar H. Schreiber · 2012 · BioTechniques
55. Thrombospondin-1 mediates oncogenic Ras–induced senescence in premalignant lung tumors
    Kwan‐Hyuck Baek, Dong‐Ha Bhang, Alexander Zaslavsky, Liang-Chuan Wang, Anil Vachani, Carla F. Kim, Steven Μ. Albelda, Gérard I. Evan, Sandra W. Ryeom · 2013 · Journal of Clinical Investigation
56. Potassium-activated GTPase Reaction in the G Protein-coupled Ferrous Iron Transporter B
    Miriam-Rose Ash, Amy P. Guilfoyle, Ronald J. Clarke, Jules Mitchell Guss, Megan J. Maher, Mika Jormakka · 2010 · Journal of Biological Chemistry
57. Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice
    H Ye, Chen‐Yu Zhang, B-J Wang, X-H Tan, W-P Zhang, Y Teng, Xiao Yi Yang · 2013 · Oncogene
58. Pigs as models of human cancers
    Tatiana Flisikowska, Alexander Kind, Angelika Schnieke · 2016 · Theriogenology
59. Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer
    Guilherme A. P. de Oliveira, Luciana Pereira Rangel, Danielly C. Ferraz da Costa, Jerson Lima Silva · 2015 · Frontiers in Oncology
60. Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS
    Iwona Stelniec‐Klotz, Stefan Legewie, Oleg I. Tchernitsa, Franziska Witzel, Bertram Klinger, Christine Sers, Hanspeter Herzel, Nils Blüthgen, Reinhold Schäfer · 2012 · Molecular Systems Biology
61. Prognostic value of RKIP and p-ERK in gastric cancer
    Yoshitaka Fujimori, Mikito Inokuchi, Yoko Takagi, Keiji Kato, Kazuyuki Kojima, Kenichi Sugihara · 2012 · Journal of Experimental & Clinical Cancer Research
62. Mechanisms of Allostery and Membrane Attachment in Ras GTPases: Implications for Anti-Cancer Drug Discovery
    Alemayehu Abebe Gorfe · 2009 · Current Medicinal Chemistry
63. K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives
    Vivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar Bharti · 2016 · European Journal of Medicinal Chemistry
64. Conformational SERS Classification of K‐Ras Point Mutations for Cancer Diagnostics
    Judit Morlà‐Folch, Patricia Gisbert‐Quilis, Matteo Masetti, Eduardo García‐Rico, Ramón A. Álvarez‐Puebla, Luca Guerrini · 2017 · Angewandte Chemie International Edition
65. Selective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy
    Mohd Javed Akhtar, Hisham A. Alhadlaq, Sudhir Kumar, Salman Alrokayan, Maqusood Ahamed · 2015 · Archives of Toxicology
66. Targeting the α4–α5 dimerization interface of K-RAS inhibits tumor formation in vivo
    Khan, Imran, Spencer-Smith, Russell, O’Bryan, John P. · 2019 · Oncogene
67. Mapping the Conformation Space of Wildtype and Mutant H-Ras with a Memetic, Cellular, and Multiscale Evolutionary Algorithm
    Rudy Clausen, Buyong Ma, Ruth Nussinov, Amarda Shehu · 2015 · PLoS Computational Biology
68. Post-translational modification of KRAS: potential targets for cancer therapy
    Weihua Wang, Tao Yuan, Meijia Qian, Fangjie Yan, Liu Yang, Qiaojun He, Bo Yang, Jin‐Jian Lu, Hong Zhu · 2020 · Acta Pharmacologica Sinica
69. Enhanced MET Translation and Signaling Sustains K-Ras–Driven Proliferation under Anchorage-Independent Growth Conditions
    Saori Fujita-Sato, Jacqueline Galeas, Morgan Truitt, Cameron Pitt, Anatoly Urisman, Sourav Bandyopadhyay, Davide Ruggero, Frank P. McCormick · 2015 · Cancer Research
70. Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
    Jehan J. El‐Jawhari, Yasser Mohamed El-Sherbiny, Gina B. Scott, Ruth S.M. Morgan, Robin J D Prestwich, Paul A. Bowles, G. Eric Blair, Tomoyuki U Tanaka, Terence Howard Rabbitts, Josephine L. Meade et al. · 2013 · Molecular Immunology
71. STAT3 Revs Up the Powerhouse
    Nancy C. Reich · 2009 · Science Signaling
72. Emerging pathways and future targets for the molecular therapy of pancreatic cancer
    Vanja Vaccaro, Davide Melisi, Emilio Bria, Federica Cuppone, Ludovica Ciuffreda, Maria Simona Pino, Alain Jonathan Gelibter, Giampaolo Tortora, Francesco Cognetti, Michèle Milella · 2011 · Expert Opinion on Therapeutic Targets
73. Compartmentalized Ras Proteins Transform NIH 3T3 Cells with Different Efficiencies
    Chiang-Min Cheng, Huiling Li, Stéphane Gasman, Jian Huang, Rachel Schiff, Eric C. Chang · 2010 · Molecular and Cellular Biology
74. The c-Jun NH2-Terminal Kinase 2 Plays a Dominant Role in Human Epidermal Neoplasia
    Hengning Ke, Rebecca Harris, Jonathan L. Coloff, Jane Y. Jin, Benjamin Leshin, Paula L. Miliani de Marval, Shiying Tao, Jeffrey C. Rathmell, Russell P. Hall, Jennifer Y. Zhang · 2010 · Cancer Research
75. Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients
    Julien Taı̈eb, Ralyath Balogoun, Karine Le Malicot, Josep M. Tabernero, Enrico Mini, Gunnar Folprecht, Jean‐Luc Van Laethem, J.-F. Emile, Claire Mulot, Serge Fratté et al. · 2016 · Annals of Oncology
76. Genotype and phenotype spectrum of NRAS germline variants
    Franziska Altmüller, Christina Lißewski, Débora Romeo Bertola, Elisabetta Flex, Zornitza Stark, Stephanie Spranger, Gareth S Baynam, Michelle Buscarilli, Sarah Dyack, Jane Gillis et al. · 2017 · European Journal of Human Genetics
77. WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation
    Woo-Jeong Jeong, Jong‐Chan Park, Woo-Shin Kim, Eun Ji Ro, Soung Hoo Jeon, Sang‐Kyu Lee, Young Nyun Park, Do Sik Min, Kang‐Yell Choi · 2019 · Nature Communications
78. USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer
    Julia M. Fraile, Eusebio Manchado, Amaia Lujambio, Vı́ctor Quesada, Diana Campos-Iglesias, Thomas R. Webb, Scott W. Lowe, Carlos López-Otı́n, José M.P. Freije · 2017 · Journal of Biological Chemistry
79. MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1
    Hongxing Shen, Chuan Xing, Kaisa Cui, Yunxiao Li, Jinxiang Zhang, Run‐Lei Du, Xiaodong Zhang, Youjun Li · 2017 · Cell Death and Differentiation
80. bFGF-mediated pluripotency maintenance in human induced pluripotent stem cells is associated with NRAS-MAPK signaling
    Fereshteh Haghighi, Julia Dahlmann, Saeideh Nakhaei‐Rad, Alexander Lang, Ingo Kutschka, Martin Zenker, George Kensah, Roland P. Piekorz, Mohammad Reza Ahmadian · 2018 · Cell Communication and Signaling
81. Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy
    Cynthia Brito Lins Pereira, Mariana Ferreira Leal, Carolina Rosal Teixeira de Souza, Raquel Carvalho Montenegro, JUAN ANTONIO REY, Antônio Alberto Carvalho, Paulo Pimentel de Assumpção, André Salim Khayat, Giovanny Rebouças Pinto, Sâmia Demachki et al. · 2013 · PLoS ONE
82. Ras, an Actor on Many Stages: Posttranslational Modifications, Localization, and Site-Specified Events
    Imanol Arozarena, Fernando Calvo, Piero Crespo · 2011 · Genes & Cancer
83. Comparison of the Conformations of KRAS Isoforms, K-Ras4A and K-Ras4B, Points to Similarities and Significant Differences
    Mayukh Chakrabarti, Hyunbum Jang, Ruth Nussinov · 2016 · The Journal of Physical Chemistry B
84. Ras signaling regulates osteoprogenitor cell proliferation and bone formation
    Garyfallia Papaioannou, Fatemeh Mirzamohammadi, Tatsuya Kobayashi · 2016 · Cell Death and Disease
85. The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer
    Khalid Omer Alfarouk, Samrein B. M. Ahmed, Ahmed Ahmed, Robert Lange Elliott, Muntaser Eltayeb Ibrahim, Heyam Saad Ali, Christian C. Wales, Ibrahim Nourwali, Ahmed N. Aljarbou, Adil H. H. Bashir et al. · 2020 · Cancers
86. The Role of Conserved Waters in Conformational Transitions of Q61H K-ras
    Priyanka Prakash, Abdallah Sayyed–Ahmad, Alemayehu Abebe Gorfe · 2012 · PLoS Computational Biology
87. Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors
    Norbert Berndt, Saı̈d M. Sebti · 2011 · Nature Protocols
88. Cell Type-Specific Activation of AKT and ERK Signaling Pathways by Small Negatively-Charged Magnetic Nanoparticles
    Jens Rauch, Walter Kölch, Morteza Mahmoudi · 2012 · Scientific Reports
89. Inhibition and Termination of Physiological Responses by GTPase Activating Proteins
    Erzsébet Ligeti, Stefan Welti, Klaus Scheffzek · 2012 · Physiological Reviews
90. Probing the Conformational and Energy Landscapes of KRAS Membrane Orientation
    Priyanka Prakash, Alemayehu Abebe Gorfe · 2019 · The Journal of Physical Chemistry B
91. The regulation of shrimp metabolism by the white spot syndrome virus (WSSV)
    Ramya Kumar, Jiun‐Yan Huang, Yen Siong Ng, Cong-Yan Chen, Han‐Ching Wang · 2021 · Reviews in Aquaculture
92. The therapeutic potential of neurofibromin signaling pathways and binding partners
    Juan Báez-Flores, Mario Rodríguez-Martín, Jesús Lacal · 2023 · Communications Biology
93. κB-Ras Proteins Regulate Both NF-κB-Dependent Inflammation and Ral-Dependent Proliferation
    Andrea Oeckinghaus, Thomas S. Postler, Ping Rao, Heike Schmitt, Verena Schmitt, Yenkel Grinberg‐Bleyer, Lars I. Kühn, Christian W. Gruber, Gustav E. Lienhard, Sankar Ghosh · 2014 · Cell Reports
94. TCR-Induced Activation of Ras Proceeds at the Plasma Membrane and Requires Palmitoylation of N-Ras
    Ignacio Rubio, Stefan Grund, Shu-Ping Song, Christoph U. Biskup, Sabine Bandemer, Melanie Fricke, Martin Förster, Andrea Graziani, Ute Wittig, Stefanie Kliche · 2010 · The Journal of Immunology
95. KRAS mutant lung cancer: progress thus far on an elusive therapeutic target
    Saveri Bhattacharya, Mark A. Socinski, Timothy Francis Burns · 2015 · Clinical and Translational Medicine
96. Lessons from computer simulations of Ras proteins in solution and in membrane
    Priyanka Prakash, Alemayehu Abebe Gorfe · 2013 · Biochimica et Biophysica Acta (BBA) - General Subjects
97. Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12V
    Christian Schmees, Roberto Villaseñor, Wei Zheng, H. Ma, Marino Zerial, Carl‐Henrik Heldin, Carina B. Hellberg · 2012 · Molecular Biology of the Cell
98. The Mediator complex of Caenorhabditis elegans: insights into the developmental and physiological roles of a conserved transcriptional coregulator
    Jennifer M. Grants, Grace Ying Shyen Goh, Stefan Taubert · 2015 · Nucleic Acids Research
99. Sos1 disruption impairs cellular proliferation and viability through an increase in mitochondrial oxidative stress in primary MEFs
    Pilar Liceras-Boillos, Rósula García‐Navas, Alicia Ginel-Picardo, Berta Anta, Martín Pérez‐Andrés, Concepción Lillo, Carmela Gómez, David Jimeno, Alberto Fernández‐Medarde, Fernando C. Baltanás et al. · 2016 · Oncogene
100. A Shortage of FTH Induces ROS and Sensitizes RAS-Proficient Neuroblastoma N2A Cells to Ferroptosis
     Ruiqing Lu, Yi-Nan Jiang, Xianxin Lai, Shujie Liu, Litao Sun, Zhongwei Zhou · 2021 · International Journal of Molecular Sciences